M3 Biotechnology m3bio.com

M3 Biotechnology is a therapeutics company that has a novel platform of pharmaceuticals that modifies growth-factor systems. It is a therapeutic approach particularly relevant to neurodegenerative diseases where activation of growth factors would be expected, at the very least, to stop disease progression and at best to restore lost function. M3 is ready to emerge into the preclinical and clinical stage of development with its lead compound, MM-201, which represents an important opportunity for ...Show all

M3 Biotechnology is a therapeutics company that has a novel platform of pharmaceuticals that modifies growth-factor systems. It is a therapeutic approach particularly relevant to neurodegenerative diseases where activation of growth factors would be ...Show all

Company (Alive / Active)

All investors data 9 Investors

• Alzheimer's Drug Discovery Foundation
• Bruce Montgomery
• Dolby Family Ventures
• Kayne Anderson Capital Advisors
• Michael Montgomery